These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2357958)

  • 1. Nifedipine as an add-on drug in the management of refractory epilepsy.
    Sander JW; Trevisol-Bittencourt PC
    Epilepsy Res; 1990; 6(1):82-4. PubMed ID: 2357958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonists as an add-on therapy for drug-resistant epilepsy.
    Chaisewikul R; Baillie N; Marson AG
    Cochrane Database Syst Rev; 2001; (4):CD002750. PubMed ID: 11687158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsants combined with nifedipine for epilepsy in adults.
    Gavranovic M; Müller T; Sofic E; Bilalbegovic Z
    Am J Psychiatry; 1991 Jun; 148(6):808-9. PubMed ID: 2035727
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nifedipine as a coadjuvant drug in the treatment of uncontrolled epilepsy: a preliminary report].
    Rotta NT; Ohlweiler L; Lago IS
    Arq Neuropsiquiatr; 1989 Mar; 47(1):118-9. PubMed ID: 2764749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nifedipine for epilepsy? A pilot study.
    Larkin JG; Butler E; Brodie MJ
    Br Med J (Clin Res Ed); 1988 Feb; 296(6621):530-1. PubMed ID: 3126893
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of vigabatrin as an add-on drug in the management of severe epilepsy.
    Sander JW; Trevisol-Bittencourt PC; Hart YM; Shorvon SD
    J Neurol Neurosurg Psychiatry; 1990 Nov; 53(11):1008-10. PubMed ID: 2283513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nifedipine for epilepsy? A double-blind, placebo-controlled trial.
    Larkin JG; Besag FM; Cox A; Williams J; Brodie MJ
    Epilepsia; 1992; 33(2):346-52. PubMed ID: 1547765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progabide as an add-on drug for epilepsy refractory to high dose antiepileptic drug therapy.
    Schmidt D
    Neurosci Lett; 1984 Jun; 47(3):357-60. PubMed ID: 6382068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamotrigine as add-on therapy in adult patients with refractory epilepsy.
    Yen DJ; Yiu CH; Kwan SY; Lin YY; Su MS
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 May; 59(5):303-7. PubMed ID: 9248123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticonvulsant activity of sodium valproate and various calcium antagonists during their combined use in mice].
    Kryzhanovskiĭ GN; Karpova MN; Abrosimov IIu; Pankov OIu; Lakinina MV
    Biull Eksp Biol Med; 1993 Mar; 115(3):231-3. PubMed ID: 8054599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate in refractory epilepsy: a prospective observational study.
    Stephen LJ; Sills GJ; Brodie MJ
    Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy.
    Russo E; Constanti A; Ferreri G; Citraro R; De Sarro G
    Neuropharmacology; 2004 May; 46(6):865-78. PubMed ID: 15033346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allopurinol as adjunctive therapy in intractable epilepsy: a double-blind and placebo-controlled trial.
    Togha M; Akhondzadeh S; Motamedi M; Ahmadi B; Razeghi S
    Arch Med Res; 2007 Apr; 38(3):313-6. PubMed ID: 17350481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Canadian Clobazam Cooperative Group.
    Epilepsia; 1991; 32(3):407-16. PubMed ID: 2044502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Epilepsy Behav; 2007 Mar; 10(2):296-303. PubMed ID: 17317325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy.
    Summers MA; Moore JL; McAuley JW
    Ann Pharmacother; 2004 Oct; 38(10):1631-4. PubMed ID: 15328394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of clobazam as add-on therapy for refractory epilepsy: experience at a US epilepsy center.
    Montenegro MA; Arif H; Nahm EA; Resor SR; Hirsch LJ
    Clin Neuropharmacol; 2008; 31(6):333-8. PubMed ID: 19050410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
    Jozwiak S; Terczynski A
    Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy and safety of levetiracetam (keppra) add-on treatment in adult patients with refractory epilepsy in two tertiary centers].
    Auriel E; Chistik V; Blatt I; Margolin N; Neufeld M
    Harefuah; 2007 Apr; 146(4):269-71, 318. PubMed ID: 17476932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report.
    Maschio M; Dinapoli L; Saveriano F; Pompili A; Carapella CM; Vidiri A; Jandolo B
    Acta Neurol Scand; 2009 Sep; 120(3):210-2. PubMed ID: 19719809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.